![](https://webarchive.library.unt.edu/eot2008/20081103234506im_/http://www.nci.nih.gov/images/spacer.gif) |
¿Preguntas sobre el cáncer?
![](https://webarchive.library.unt.edu/eot2008/20081103234506im_/http://www.nci.nih.gov/images/spacer.gif)
|
1-800-422-6237
(1-800-4-CANCER)
|
![](https://webarchive.library.unt.edu/eot2008/20081103234506im_/http://www.nci.nih.gov/images/spacer.gif)
|
Llame de lunes a viernes de 9:00 a.m. a 4:30 p.m., hora local en Estados Unidos y sus territorios. |
|
![](https://webarchive.library.unt.edu/eot2008/20081103234506im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081103234506im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081103234506im_/http://www.nci.nih.gov/images/spacer.gif)
| Sustancia que se ha estudiado en el tratamiento de algunos tipos de cáncer. El rAd/p53 es un adenovirus atenuado (debilitado) que conduce el gen p53 hasta las células tumorales, haciendo que mueran. Es un tipo de terapia genética. También se llama adenovirus genotecnológico-p53, ACN53 y SCH-58500. |
![](https://webarchive.library.unt.edu/eot2008/20081103234506im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081103234506im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081103234506im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081103234506im_/http://www.nci.nih.gov/images/spacer.gif) |